Relative Binding Free Energy Calculations Applied to Protein Homology Models

被引:52
作者
Cappel, Daniel [1 ]
Hall, Michelle Lynn [2 ,5 ]
Lenselink, Eelke B. [3 ]
Beuming, Thijs [2 ]
Qi, Jun [4 ]
Bradner, James [4 ,6 ]
Sherman, Woody [2 ]
机构
[1] Schrodinger GmbH, Dynamostr 13, D-68165 Mannheim, Germany
[2] Schrodinger Inc, 120 W 45th St, New York, NY 10036 USA
[3] Leiden Univ, Div Med Chem, Leiden Acad Ctr Drug Res, NL-2333 CC Leiden, Netherlands
[4] Harvard Med Sch, Dept Med, Dana Farber Canc Inst, Dept Med Oncol, 360 Longwood Ave,LC 2210, Boston, MA 02215 USA
[5] Moderna Therapeut, 200 Technol Sq, Cambridge, MA 02139 USA
[6] Novartis Inst BioMed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA
关键词
HIV-1; REVERSE-TRANSCRIPTASE; DRUG-LIKE MOLECULES; INDUCED FIT DOCKING; FORCE-FIELD; LEAD OPTIMIZATION; NONNUCLEOSIDE INHIBITORS; SCORING FUNCTIONS; ACCURATE DOCKING; REPLICA EXCHANGE; TYK2; INHIBITORS;
D O I
10.1021/acs.jcim.6b00362
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A significant challenge and potential high-value application of computer-aided drug design is the accurate prediction of protein ligand binding affinities. Free energy perturbation (FEP) using molecular dynamics (MD) sampling is among the most suitable approaches to achieve accurate binding free energy predictions, due to the rigorous statistical framework of the methodology, correct representation of the energetics, and thorough treatment of the important degrees of freedom in the system (including explicit waters). Recent advances in sampling methods and force fields coupled with vast increases in computational resources have made FEP a viable technology to drive hit-to-lead and lead optimization, allowing for more efficient cycles of medicinal chemistry and the possibility to explore much larger chemical spaces. However, previous FEP applications have focused on systems with high resolution crystal structures of the target as starting points something that is not always available in drug discovery projects. As such, the ability to apply FEP on homology models would greatly expand the domain of applicability of FEP in drug discovery. In this work we apply a particular implementation of FEP, called FEP+, on congeneric ligand series binding to four diverse targets: a kinase (Tyk2), an epigenetic bromodomain (BRD4), a transmembrane GPCR (A(2A)), and a protein protein interaction interface (BCL-2 family protein MCL-1). We apply FEP+ using both crystal structures and homology models as starting points and find that the performance using homology models is generally on a par with the results when using crystal structures. The robustness of the calculations to structural variations in the input models can likely be attributed to the conformational sampling in the molecular dynamics simulations, which allows the modeled receptor to adapt to the "real" conformation for each ligand in the series. This work exemplifies the advantages of using all-atom simulation methods with full system flexibility and offers promise for the general application of FEP to homology models, although additional validation studies should be performed to further understand the limitations of the method and the scenarios where FEP will work best.
引用
收藏
页码:2388 / 2400
页数:13
相关论文
共 76 条
[41]   Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors [J].
Liang, Jun ;
van Abbema, Anne ;
Balazs, Mercedesz ;
Barrett, Kathy ;
Berezhkovsky, Leo ;
Blair, Wade ;
Chang, Christine ;
Delarosa, Donnie ;
DeVoss, Jason ;
Driscoll, Jim ;
Eigenbrot, Charles ;
Ghilardi, Nico ;
Gibbons, Paul ;
Halladay, Jason ;
Johnson, Adam ;
Kohli, Pawan Bir ;
Lai, Yingjie ;
Liu, Yanzhou ;
Lyssikatos, Joseph ;
Mantik, Priscilla ;
Menghrajani, Kapil ;
Murray, Jeremy ;
Peng, Ivan ;
Sambrone, Amy ;
Shia, Steven ;
Shin, Young ;
Smith, Jan ;
Sohn, Sue ;
Tsui, Vickie ;
Ultsch, Mark ;
Wu, Lawren C. ;
Xiao, Yisong ;
Yang, Wenqian ;
Young, Judy ;
Zhang, Birong ;
Zhu, Bing-yan ;
Magnuson, Steven .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (11) :4521-4536
[42]   Replica exchange with solute tempering: A method for sampling biological systems in explicit water [J].
Liu, P ;
Kim, B ;
Friesner, RA ;
Berne, BJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (39) :13749-13754
[43]   OPM: Orientations of proteins in membranes database [J].
Lomize, MA ;
Lomize, AL ;
Pogozheva, ID ;
Mosberg, HI .
BIOINFORMATICS, 2006, 22 (05) :623-625
[44]   Computational Study of the "DFG-Flip" Conformational Transition in c-Abl and c-Src Tyrosine Kinases [J].
Meng, Yilin ;
Lin, Yen-lin ;
Roux, Benoit .
JOURNAL OF PHYSICAL CHEMISTRY B, 2015, 119 (04) :1443-1456
[45]   Prediction of protein-ligand binding affinity by free energy simulations: assumptions, pitfalls and expectations [J].
Michel, Julien ;
Essex, Jonathan W. .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2010, 24 (08) :639-658
[46]   Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 [J].
Michino, Mayako ;
Abola, Enrique ;
Brooks, Charles L., III ;
Dixon, J. Scott ;
Moult, John ;
Stevens, Raymond C. ;
Olson, Arthur ;
Jurkowski, Wiktor ;
Elofsson, Arne ;
Filipek, Slawomir ;
Pogozheva, Irina ;
Lomize, Andrei ;
Maigret, Bernard ;
Horst, Jeremy ;
Bernard, Brady ;
Iyer, Shyamala ;
Samudrala, Ram ;
Roy, Ambrish ;
Zhang, Yang ;
Sezerman, Osman Ugur ;
Nikiforovich, Gregory V. ;
Taylor, Christina M. ;
Costanzi, Stefano ;
Vorobjev, Y. ;
Bakulina, N. ;
Solovyev, V. ;
Kanou, Kazuhiko ;
Takaya, Daisuke ;
Terashi, Genki ;
Takeda-Shitaka, Mayuko ;
Umeyama, Hideaki ;
Goddard, William A., III ;
Li, Youyong ;
Kim, Soo-Kyung ;
Trzaskowski, Bartosz ;
Abrol, Ravinder ;
Griffith, Adam ;
Katritch, Vsevolod ;
Rueda, Manuel ;
Davis, Ian ;
Barth, Patrick ;
Baker, David ;
Feig, Michael ;
Brylinski, Michal ;
Zhou, Hongyi ;
Lee, Seung Yup ;
Skolnick, Jeffrey ;
Ostopovici-Halip, Liliana ;
Bologa, Cristian ;
Lam, Polo .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (06) :455-463
[47]   A Large-Scale Test of Free-Energy Simulation Estimates of Protein Ligand Binding Affinities [J].
Mikulskis, Paulius ;
Genheden, Samuel ;
Ryde, Ulf .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (10) :2794-2806
[48]   2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists.: Design, synthesis, and pharmacological characterization [J].
Minetti, P ;
Tinti, MO ;
Carminati, P ;
Castorina, M ;
Di Cesare, MA ;
Di Serio, S ;
Gallo, G ;
Ghirardi, O ;
Giorgi, F ;
Giorgi, L ;
Piersanti, G ;
Bartoccini, F ;
Tarzia, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (22) :6887-6896
[49]   Predicting absolute ligand binding free energies to a simple model site [J].
Mobley, David L. ;
Graves, Alan P. ;
Chodera, John D. ;
McReynolds, Andrea C. ;
Shoichet, Brian K. ;
Dill, Ken A. .
JOURNAL OF MOLECULAR BIOLOGY, 2007, 371 (04) :1118-1134
[50]   GPCRdb: the G protein-coupled receptor database - an introduction [J].
Munk, C. ;
Isberg, V. ;
Mordalski, S. ;
Harpsoe, K. ;
Rataj, K. ;
Hauser, A. S. ;
Kolb, P. ;
Bojarski, A. J. ;
Vriend, G. ;
Gloriam, D. E. .
BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (14) :2195-2207